• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tumor stromal topography promotes chemoresistance in migrating breast cancer cell clusters.肿瘤基质拓扑结构促进迁移性乳腺癌细胞簇的化疗耐药性。
Biomaterials. 2023 Jul;298:122128. doi: 10.1016/j.biomaterials.2023.122128. Epub 2023 Apr 21.
2
DEHP mediates drug resistance by directly targeting AhR in human breast cancer.DEHP 通过直接靶向人乳腺癌中的 AhR 介导药物耐药性。
Biomed Pharmacother. 2022 Jan;145:112400. doi: 10.1016/j.biopha.2021.112400. Epub 2021 Nov 18.
3
Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer.灶周脂肪来源干细胞促进乳腺癌的化疗耐药性。
Stem Cell Res Ther. 2017 Jul 27;8(1):177. doi: 10.1186/s13287-017-0630-2.
4
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.miRNA-449 家族通过调节细胞周期因子介导三阴性乳腺癌对多柔比星的耐药性。
Sci Rep. 2019 Mar 29;9(1):5316. doi: 10.1038/s41598-019-41472-y.
5
Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.通过沉默 STAT3、Notch-1 和 β-catenin 基因增强野生型和耐药 MDA-MB-231 三阴性乳腺癌细胞系对多柔比星的化疗敏感性。
Breast Cancer. 2020 Sep;27(5):989-998. doi: 10.1007/s12282-020-01098-9. Epub 2020 Apr 23.
6
Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.芳基烃受体通过增强三阴性乳腺癌细胞中 AKR1C3 的表达来拮抗多柔比星的药理作用。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):693-698. doi: 10.1016/j.bbrc.2019.06.119. Epub 2019 Jun 26.
7
Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer.适应性耐药并不是三阴性乳腺癌细胞模型中产生长期耐药的原因。
Gene. 2023 Jan 20;850:146930. doi: 10.1016/j.gene.2022.146930. Epub 2022 Oct 3.
8
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.二甲双胍、乙酰水杨酸和磷酸奥司他韦三联组合影响肿瘤球状体活力并颠覆三阴性乳腺癌的化疗耐药性。
Drug Des Devel Ther. 2020 May 25;14:1995-2019. doi: 10.2147/DDDT.S242514. eCollection 2020.
9
Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.双重靶向 MDM2/MDMX 抑制剂通过激活 TAB1/TAK1/p38 MAPK 通路增加阿霉素的敏感性,并抑制三阴性乳腺癌细胞的迁移和侵袭能力。
Cancer Biol Ther. 2019;20(5):617-632. doi: 10.1080/15384047.2018.1539290. Epub 2018 Nov 21.
10
Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells Apoptosis.恩杂鲁胺克服了三阴性乳腺癌细胞中双氢睾酮诱导的化疗耐药 凋亡。
Anticancer Agents Med Chem. 2022;22(17):3038-3048. doi: 10.2174/1871520622666220509123505.

引用本文的文献

1
Extracellular Matrix Signaling Cues: Biological Functions, Diseases, and Therapeutic Targets.细胞外基质信号线索:生物学功能、疾病及治疗靶点
MedComm (2020). 2025 Jul 17;6(8):e70281. doi: 10.1002/mco2.70281. eCollection 2025 Aug.
2
High-Throughput 96-Well Nanogroove-Enhanced Electrical Impedance Biosensor for Real-Time Label-Free Cancer Drug Screening.用于实时无标记癌症药物筛选的高通量96孔纳米槽增强电阻抗生物传感器。
Adv Healthc Mater. 2025 Jun 18:e2402057. doi: 10.1002/adhm.202402057.
3
In silico development and validation of a novel six-gene-derived signature in hepatocellular carcinoma.肝细胞癌中一种新型六基因衍生特征的计算机开发与验证
Transl Cancer Res. 2025 May 30;14(5):2940-2955. doi: 10.21037/tcr-2024-2621. Epub 2025 May 27.
4
Cancer-on-a-chip for precision cancer medicine.用于精准癌症医学的芯片上的癌症模型
Lab Chip. 2025 May 16. doi: 10.1039/d4lc01043d.
5
Engineering multifunctional surface topography to regulate multiple biological responses.设计多功能表面形貌以调控多种生物学反应。
Biomaterials. 2025 Aug;319:123136. doi: 10.1016/j.biomaterials.2025.123136. Epub 2025 Jan 28.
6
Effects of Confined Microenvironments with Protein Coating, Nanotopography, and TGF-β Inhibitor on Nasopharyngeal Carcinoma Cell Migration through Channels.蛋白质包被、纳米拓扑结构和TGF-β抑制剂的受限微环境对鼻咽癌细胞通过通道迁移的影响
J Funct Biomater. 2024 Sep 11;15(9):263. doi: 10.3390/jfb15090263.
7
The importance of 3D fibre architecture in cancer and implications for biomaterial model design.三维纤维结构在癌症中的重要性及其对生物材料模型设计的影响。
Nat Rev Cancer. 2024 Jul;24(7):461-479. doi: 10.1038/s41568-024-00704-8. Epub 2024 Jun 17.

本文引用的文献

1
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis.对自然杀伤细胞免疫监视的抗性赋予多克隆转移选择性优势。
Nat Cancer. 2020 Jul;1(7):709-722. doi: 10.1038/s43018-020-0068-9. Epub 2020 Jun 1.
2
Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma.基质结构指导胰腺导管腺癌的早期扩散。
JCI Insight. 2022 Feb 8;7(3):e150330. doi: 10.1172/jci.insight.150330.
3
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.乳腺癌患者首次诊断后 10-32 年内的复发情况。
J Natl Cancer Inst. 2022 Mar 8;114(3):391-399. doi: 10.1093/jnci/djab202.
4
Engineering a 3D collective cancer invasion model with control over collagen fiber alignment.工程化具有胶原纤维定向控制的 3D 集体癌症浸润模型。
Biomaterials. 2021 Aug;275:120922. doi: 10.1016/j.biomaterials.2021.120922. Epub 2021 Jun 4.
5
Cancer cell metabolic plasticity in migration and metastasis.肿瘤细胞迁移和转移中的代谢可塑性。
Clin Exp Metastasis. 2021 Aug;38(4):343-359. doi: 10.1007/s10585-021-10102-1. Epub 2021 Jun 2.
6
Is there a universal mechanism of cell alignment in response to substrate topography?是否存在一种响应底物拓扑结构的细胞排列通用机制?
Cytoskeleton (Hoboken). 2021 Jun;78(6):284-292. doi: 10.1002/cm.21661. Epub 2021 Apr 24.
7
Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.乳腺癌瘤内细胞色素P450表达:对标准治疗的影响及开发肿瘤选择性疗法的新进展
Biomedicines. 2021 Mar 12;9(3):290. doi: 10.3390/biomedicines9030290.
8
CYP1B1 as a therapeutic target in cardio-oncology.CYP1B1 作为心脏肿瘤学中的治疗靶点。
Clin Sci (Lond). 2020 Nov 13;134(21):2897-2927. doi: 10.1042/CS20200310.
9
Concepts of extracellular matrix remodelling in tumour progression and metastasis.肿瘤进展和转移中外细胞基质重塑的概念。
Nat Commun. 2020 Oct 9;11(1):5120. doi: 10.1038/s41467-020-18794-x.
10
Tumour budding in solid cancers.实体癌中的肿瘤芽生
Nat Rev Clin Oncol. 2021 Feb;18(2):101-115. doi: 10.1038/s41571-020-0422-y. Epub 2020 Sep 8.

肿瘤基质拓扑结构促进迁移性乳腺癌细胞簇的化疗耐药性。

Tumor stromal topography promotes chemoresistance in migrating breast cancer cell clusters.

机构信息

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, United States.

Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, United States.

出版信息

Biomaterials. 2023 Jul;298:122128. doi: 10.1016/j.biomaterials.2023.122128. Epub 2023 Apr 21.

DOI:10.1016/j.biomaterials.2023.122128
PMID:37121102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10291492/
Abstract

Multicellular clustering provides cancer cells with survival advantages and facilitates metastasis. At the tumor migration front, cancer cell clusters are surrounded by an aligned stromal topography. It remains unknown whether aligned stromal topography regulates the resistance of migrating cancer cell clusters to therapeutics. Using a hybrid nanopatterned model to characterize breast cancer cell clusters at the migration front with aligned stromal topography, we demonstrate that topography-induced migrating cancer cell clusters exhibit upregulated cytochrome P450 family 1 (CYP1) drug metabolism and downregulated glycolysis gene signatures, which correlates with unfavorable prognosis. Screening on approved oncology drugs shows that cancer cell clusters on aligned stromal topography are more resistant to diverse chemotherapeutics. Full-dose drug testings further indicate that topography induces drug resistance of hormone receptor-positive breast cancer cell clusters to doxorubicin and tamoxifen and triple-negative breast cancer cell clusters to doxorubicin by activating the aryl hydrocarbon receptor (AhR)/CYP1 pathways. Inhibiting the AhR/CYP1 pathway restores reactive oxygen species-mediated drug sensitivity to migrating cancer cell clusters, suggesting a plausible therapeutic direction for preventing metastatic recurrence.

摘要

细胞簇聚为癌细胞提供了生存优势,并促进了转移。在肿瘤迁移前沿,癌细胞簇被排列整齐的基质地形所包围。目前尚不清楚排列整齐的基质地形是否调节了迁移癌细胞簇对治疗的耐药性。本研究使用混合纳米图案模型来描述具有排列整齐的基质地形的迁移前沿的乳腺癌细胞簇,结果表明,拓扑结构诱导的迁移癌细胞簇表现出上调的细胞色素 P450 家族 1(CYP1)药物代谢和下调的糖酵解基因特征,这与不良预后相关。对已批准的肿瘤学药物进行筛选表明,排列整齐的基质地形上的癌细胞簇对多种化疗药物的耐药性更强。全剂量药物测试进一步表明,拓扑结构通过激活芳香烃受体(AhR)/CYP1 途径诱导激素受体阳性乳腺癌细胞簇对阿霉素和他莫昔芬以及三阴性乳腺癌细胞簇对阿霉素的耐药性。抑制 AhR/CYP1 途径可恢复迁移癌细胞簇对活性氧介导的药物敏感性,提示了一种预防转移性复发的合理治疗方向。